Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsFaricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration.
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss.
The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be a false positive for cyclospora, saying the reversal does not...
Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...
Sri Lanka's public health services and hospitals are battling the worst outbreak of mosquito-borne dengue in nearly a decade, and turning to the island nation's armed...
Older adults with lower gastrointestinal bleeding present with more severe disease and substantially higher 30-day mortality—yet most deaths stem not from bleeding itself, but from decompensation of underlying chronic conditions.
A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.
1.
Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.
2.
Investigating the Relationship Between GERD and Anxiety/Depression.
3.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
4.
The use of biomarkers in the treatment of breast lumps is at a crossroads.
5.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
1.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
2.
Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics
3.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
4.
Tumor Dormancy and Cancer Recurrence: Mechanisms, Clinical Implications, and Future Directions
5.
What Is A Normal Fibrinogen Level, And How Can It Affect Your Health
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge